Filing Details
- Accession Number:
- 0001127602-16-048046
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-04-01 13:11:15
- Reporting Period:
- 2016-03-30
- Filing Date:
- 2016-04-01
- Accepted Time:
- 2016-04-01 13:11:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1454748 | Jr. T. James Boyle | 531 South Spring Street Burlington NC 27215 | Evp,Ceo Of Labcorp Diagnostics | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-03-30 | 34,737 | $0.00 | 58,191 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2016-03-30 | 16,605 | $117.85 | 41,586 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2016-03-31 | 13,191 | $116.67 | 28,395 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-31 | 4,941 | $117.19 | 23,454 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares acquired on March 30, 2016, pursuant to a performance award granted on February 12, 2013, relating to performance during the three-year period ended December 31, 2015.
- Stock withholding to satisfy tax withholding obligations.
- Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
- The price of $116.67 per share represents a weighted average of sales prices ranging from $116.10 to $117.09 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- The price of $117.19 per share represents a weighted average of sales prices ranging from $117.10 to $117.39 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Billionaire Hedge Funds
